See also this year's filing and all EDGAR filings for this company.
PDF Report 0001412486_2019_Cocrystal_Pharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001412486')"} |
Graph
Absolute values for 0001412486, Cocrystal Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,943,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 65,195,000 |
| 2 | PropertyPlantAndEquipmentNet | 384,000 |
| 3 | remainder_Assets | 40,000 |
| 4 | LiabilitiesCurrent | 1,557,000 |
| 5 | LiabilitiesNoncurrent | 117,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,352,000 |
| 9 | ResearchAndDevelopmentExpense | 58,572,000 |
| 10 | remainder_Expenses | -13,582,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 294,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 68,562,000 |
| 1 | Liabilities | 1,674,000 |
| 2 | Expenses | 49,342,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 66,888,000 |
| 5 | NetIncome | -49,048,000 |
| 6 | ComprehensiveNetIncome | -49,048,000 |
| 7 | BaseVar | 59,936,000 |
| 8 | EconomicCapitalRatio | 1.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
